294 related articles for article (PubMed ID: 22539471)
1. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
[TBL] [Abstract][Full Text] [Related]
2. Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.
Tripathi P; Ray S; Sunder S; Dube A; Naik S
Clin Exp Immunol; 2006 Feb; 143(2):380-8. PubMed ID: 16412064
[TBL] [Abstract][Full Text] [Related]
3. Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis.
Singh OP; Stober CB; Singh AK; Blackwell JM; Sundar S
PLoS Negl Trop Dis; 2012; 6(10):e1874. PubMed ID: 23150744
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
5. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence for role of anti-saliva antibodies against salivary gland homogenate of P. argentipes in modulation of protective Th1-immune response against Leishmania donovani.
Pushpanjali ; Thakur AK; Purkait B; Jamal F; Singh MK; Ahmed G; Bimal S; Kumar V; Singh SK; Keshri S; Das P; Narayan S
Cytokine; 2016 Oct; 86():79-85. PubMed ID: 27484246
[TBL] [Abstract][Full Text] [Related]
7. Whole blood assay and visceral leishmaniasis: Challenges and promises.
Singh OP; Sundar S
Immunobiology; 2014 Apr; 219(4):323-8. PubMed ID: 24571797
[TBL] [Abstract][Full Text] [Related]
8. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
9. Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
Portela ÁSB; Costa LE; Salles BCS; Lima MP; Santos TTO; Ramos FF; Lage DP; Martins VT; Caligiorne RB; Lessa DR; Silva FR; Machado AS; Nascimento GF; Gama IS; Chávez-Fumagalli MA; Teixeira AL; Rocha MOC; Rocha RL; Coelho EAF
Immunobiology; 2018 Mar; 223(3):303-309. PubMed ID: 29074301
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study.
Gidwani K; Jones S; Kumar R; Boelaert M; Sundar S
PLoS Negl Trop Dis; 2011 Apr; 5(4):e1042. PubMed ID: 21526219
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
Wolday D; Berhe N; Britton S; Akuffo H
AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
Hailu A; van der Poll T; Berhe N; Kager PA
Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
[TBL] [Abstract][Full Text] [Related]
13. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation in human dendritic cells leads to induction of interferon-gamma production by Leishmania donovani derived KMP-11 antigen via activation of NF-κB in Indian kala-azar patients.
Chaudhary R; Amit A; Yadav A; Singh A; Kumar V; Singh SK; Narayan S; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Biomed Res Int; 2014; 2014():947606. PubMed ID: 24587999
[TBL] [Abstract][Full Text] [Related]
15. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
Front Immunol; 2021; 12():773983. PubMed ID: 34777391
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.
Khare P; Jaiswal AK; Tripathi CD; Joshi S; Sundar S; Dube A
Parasitol Res; 2014 Mar; 113(3):851-62. PubMed ID: 24370734
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
Kushawaha PK; Gupta R; Tripathi CD; Sundar S; Dube A
PLoS One; 2012; 7(4):e35670. PubMed ID: 22539989
[TBL] [Abstract][Full Text] [Related]
20. IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.
Bhattacharyya T; Ayandeh A; Falconar AK; Sundar S; El-Safi S; Gripenberg MA; Bowes DE; Thunissen C; Singh OP; Kumar R; Ahmed O; Eisa O; Saad A; Silva Pereira S; Boelaert M; Mertens P; Miles MA
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3273. PubMed ID: 25340782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]